Xilma Rosa Ortiz-Gonzalez

Xilma Rosa Ortiz-Gonzalez

Auto-generated profile, based on publicly available information

Xilma Rosa Ortiz-Gonzalez

Division of Neurology, Children's Hospital of Philadelphia, PA; and

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2002 in Nature
Verified
Journal Article
Closed access
PDF file
YJYuehua Jiang
Yuehua Jiang
BJBalkrishna N. Jahagirdar
Balkrishna N. Jahagirdar
RRR. Lee Reinhardt
R. Lee Reinhardt
RSRobert E. Schwartz
Robert E. Schwartz
CKC. Dirk Keene
C. Dirk Keene
Catherine VerfaillieCatherine Verfaillie
Catherine Verfaillie

25 November 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
EMErik S. Musiek
Erik S. Musiek
MLMiranda M. Lim
Miranda M. Lim
GYGuangrui Yang
Guangrui Yang
ABAdam Q. Bauer
Adam Q. Bauer
LQLaura Qi
Laura Qi
GFGarret A. FitzGerald
Garret A. FitzGerald
Brain aging is associated with diminished circadian clock output and decreased expression of the core clock proteins, which regulate many aspects of cellular biochemistry and metabolism. The genes encoding clock proteins are expressed throughout the brain, though it is unknown whether these proteins modulate brain homeostasis. We observed that deletion of circadian clock transcriptional activators aryl hydrocarbon receptor nuclear translocator–like (Bmal1) alone, or circadian locomotor output cycles kaput (Clock) in combination with neuronal PAS domain protein 2 (Npas2), induced severe age-dependent astrogliosis in the cortex and hippocampus. Mice lacking the clock gene repressors period circadian clock 1 (Per1) and period circadian clock 2 (Per2) had no observed astrogliosis. Bmal1 deletion caused the degeneration of synaptic terminals and impaired cortical functional connectivity, as well as neuronal oxidative damage and impaired expression of several redox defense genes. Targeted deletion of Bmal1 in neurons and glia caused similar neuropathology, despite the retention of intact circadian behavioral and sleep-wake rhythms. Reduction of Bmal1 expression promoted neuronal death in primary cultures and in mice treated with a chemical inducer of oxidative injury and striatal neurodegeneration. Our findings indicate that BMAL1 in a complex with CLOCK or NPAS2 regulates cerebral redox homeostasis and connects impaired clock gene function to neurodegeneration.

1 October 2016 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
JMJohn J. Millichap
John J. Millichap
KPKristen L. Park
Kristen L. Park
TTTammy Tsuchida
Tammy Tsuchida
BBBruria Ben-Zeev
Bruria Ben-Zeev
LCLionel Carmant
Lionel Carmant
ECEdward Cooper
Edward Cooper
Objective: To advance the understanding of KCNQ2 encephalopathy genotype–phenotype relationships and to begin to assess the potential of selective KCNQ channel openers as targeted treatments. Methods: We retrospectively studied 23 patients with KCNQ2 encephalopathy, including 11 treated with ezogabine (EZO). We analyzed the genotype–phenotype relationships in these and 70 previously described patients. Results: The mean seizure onset age was 1.8 ± 1.6 (SD) days. Of the 20 EEGs obtained within a week of birth, 11 showed burst suppression. When new seizure types appeared in infancy (15 patients), the most common were epileptic spasms (n = 8). At last follow-up, seizures persisted in 9 patients. Development was delayed in all, severely in 14. The KCNQ2 variants identified introduced amino acid missense changes or, in one instance, a single residue deletion. They were clustered in 4 protein subdomains predicted to poison tetrameric channel functions. EZO use (assessed by the treating physicians and parents) was associated with improvement in seizures and/or development in 3 of the 4 treated before 6 months of age, and 2 of the 7 treated later; no serious side effects were observed. Conclusions: KCNQ2 variants cause neonatal-onset epileptic encephalopathy of widely varying severity. Pathogenic variants in epileptic encephalopathy are clustered in “hot spots” known to be critical for channel activity. For variants causing KCNQ2 channel loss of function, EZO appeared well tolerated and potentially beneficial against refractory seizures when started early. Larger, prospective studies are needed to enable better definition of prognostic categories and more robust testing of novel interventions. Classification of evidence: This study provides Class IV evidence that EZO is effective for refractory seizures in patients with epilepsy due to KCNQ2 encephalopathy.

1 October 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
DLDong Li
Dong Li
HYHongjie Yuan
Hongjie Yuan
XOXilma R. Ortiz-Gonzalez
Xilma R. Ortiz-Gonzalez
EMEric D. Marsh
Eric D. Marsh
LTLifeng Tian
Lifeng Tian
MFMarni J. Falk
Marni J. Falk

1 September 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
ATAkemi J. Tanaka
Akemi J. Tanaka
MCMegan T. Cho
Megan T. Cho
FMFrancisca Millan
Francisca Millan
JJJane Juusola
Jane Juusola
KRKyle Retterer
Kyle Retterer
WCWendy K. Chung
Wendy K. Chung

1 April 1998 in NeuroReport
Verified
Journal Article
Closed access
TOTimothy H. Olson
Timothy H. Olson
MRMaureen S. Riedl
Maureen S. Riedl
LVLucy Vulchanova
Lucy Vulchanova
XOXilma R. Ortiz-Gonzalez
Xilma R. Ortiz-Gonzalez
RERobert Elde
Robert Elde
THE acid sensing ion channel (ASIC) identified in rat brain and spinal cord is potentially involved in the transmission of acid-induced nociception. We have developed polyclonal antisera against ASIC, and used them to screen rat brain and spinal cord using immunocyto-chemistry. ASIC-immunoreactivity (-ir) is present in but not limited to the superficial dorsal horn, the dorsal root ganglia (DRG) and the spinal trigeminal nucleus, as well as peripheral nerve fibers. These observations, combined with the disappearance of ASIC-ir following dorsal rhizotomy, suggest localization of ASIC to primary afferents. DRG ASIC-ir co-localizes with substance P (SP) and calcitonin gene-related peptide (CGRP)-ir in small capsaicin-sensitive cell bodies, suggesting that ASIC is poised to play a role in the transduction of noxious stimuli.